Clinical Trial Update: Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial exploring intramuscular polymerized type I collagen for modulation of cytokine storm in COVID-19 patients with inflammatory and pulmonary invo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Storm
• Pulmonary Fibrosis

Drugs mentioned

• Polymerized Type I Collagen (polymerized type I collagen)

Snippet

Sponsor: Janette Furuzawa Carballeda | Conditions: Covid19, Cytokine Storm | Phase 1, Phase 2 | Status: UNKNOWN